Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_151_библиотеки_им_акад_М_И_Перельмана
.pdf
The Role of Tumor Microenvironment in Colon Cancer 205
https://t.me/med1917
References
Al-Badran SS, Grant L, Campo MV, Inthagard J, Pennel K, Quinn J, Konanahalli P, Hayman L,
Horgan PG, McMillan DC, Roxburgh CS, Roseweir A, Park JH, Edwards J (2021) Relationship
between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis
in primary operable colorectal cancer. J Pathol Clin Res 7:121–134. https://doi.org/10.1002/
cjp2.193
Alexander PG, McMillan DC, Park JH (2020) The local inflammatory response in colorectal
cancer – type, location or density? A systematic review and meta-analysis. Cancer Treat Rev
83:101949. https://doi.org/10.1016/j.ctrv.2019.101949. Epub 2019 Dec 11. PMID: 31869737
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE,
Compton CC, Hess KR et al (eds) (2017) AJCC cancer staging manual (8th edition). Springer
International Publishing/American Joint Commission on Cancer, New York
Baeten CI, Castermans K, Hillen HF, Griffioen AW (2006) Proliferating endothelial cells and
leukocyte infiltration as prognostic markers in colorectal cancer. Clin Gastroenterol Hepatol
4(11):1351–1357. https://doi.org/10.1016/j.cgh.2006.08.005. Epub 2006 Oct 23. PMID:
17059898
Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M,
Kolahian S, Javaheri T, Zare P (2020) Tumor microenvironment complexity and therapeutic
implications at a glance. Cell Commun Signal 18(1):59. https://doi.org/10.1186/s12964-020-
0530-4. PMID: 32264958; PMCID: PMC7140346
Bai J, Chen H, Bai X (2021) Relationship between microsatellite status and immune microenviron-
ment of colorectal cancer and its application to diagnosis and treatment. J Clin Lab Anal 35(6):
e23810. https://doi.org/10.1002/jcla.23810. Epub 2021 May 3. PMID: 33938589; PMCID:
PMC8183910
Berntsson J, Nodin B, Eberhard J, Micke P, Jirström K (2016) Prognostic impact of tumour-
infiltrating B cells and plasma cells in colorectal cancer. Int J Cancer 139(5):1129–1139.
https://doi.org/10.1002/ijc.30138. Epub 2016 May 6. PMID: 27074317
Berntsson J, Svensson MC, Leandersson K, Nodin B, Micke P, Larsson AH, Eberhard J, Jirström K
(2017) The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by
anatomical subsite: a cohort study. Int J Cancer 141(8):1654–1666. https://doi.org/10.1002/ijc.
30869. Epub 2017 Jul 20. PMID: 28677162; PMCID: PMC5601279
Berry RS, Xiong MJ, Greenbaum A, Mortaji P, Nofchissey RA, Schultz F, Martinez C, Luo L,
Morris KT, Hanson JA (2017) High levels of tumor-associated neutrophils are associated with
improved overall survival in patients with stage II colorectal cancer. PLoS One 12(12):
e0188799. https://doi.org/10.1371/journal.pone.0188799. PMID: 29211768; PMCID:
PMC5718511
Borst J, Ahrends T, Bąbała N, Melief CJM, Kastenmüller W (2018) CD4+ T cell help in cancer
immunology and immunotherapy. Nat Rev Immunol 18(10):635–647. https://doi.org/10.1038/
s41577-018-0044-0. PMID: 30057419
Canna K, McArdle PA, McMillan DC, McNicol AM, Smith GW, McKee RF, McArdle CS (2005)
The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response
and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 92(4):
651–654. https://doi.org/10.1038/sj.bjc.6602419. PMID: 15700032; PMCID: PMC2361875
Chalikonda G, Lee H, Sheik A, Huh YS (2021) Targeting key transcriptional factor STAT3 in
colorectal cancer. Mol Cell Biochem 476(9):3219–3228. https://doi.org/10.1007/s11010-021-
04156-8. Epub 2021 Apr 18. PMID: 33866491
Chen J, Chen Z (2014) The effect of immune microenvironment on the progression and prognosis
of colorectal cancer. Med Oncol 31(8):82. https://doi.org/10.1007/s12032-014-0082-9. Epub
2014 July 18. PMID: 25034363
Chen Y, Yuan R, Wu X, He X, Zeng Y, Fan X, Wang L, Wang J, Lan P, Wu X (2016) A novel
immune marker model predicts oncological outcomes of patients with colorectal cancer. Ann
Surg Oncol 23(3):826–832. https://doi.org/10.1245/s10434-015-4889-1. Epub 2015 Nov
18. PMID: 26581202
206 C. Fattorini et al.
https://t.me/med1917
Chiba T, Ohtani H, Mizoi T, Naito Y, Sato E, Nagura H, Ohuchi A, Ohuchi K, Shiiba K,
Kurokawa Y, Satomi S (2004) Intraepithelial CD8+ T-cell-count becomes a prognostic factor
after a longer follow-up period in human colorectal carcinoma: possible association with
suppression of micrometastasis. Br J Cancer 91(9):1711–1717. https://doi.org/10.1038/sj.bjc.
6602201. PMID: 15494715; PMCID: PMC2410024
Choi SY, Sung R, Lee SJ, Lee TG, Kim N, Yoon SM, Lee EJ, Chae HB, Youn SJ, Park SM (2013)
Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are
associated with different prognosis in colorectal cancers. J Korean Med Sci 28(9):1293–1301.
https://doi.org/10.3346/jkms.2013.28.9.1293. Epub 2013 Aug 28. PMID: 24015033; PMCID:
PMC3763102
Coca S, Perez-Piqueras J, Martinez D, Colmenarejo A, Saez MA, Vallejo C, Martos JA, Moreno M
(1997) The prognostic significance of intratumoral natural killer cells in patients with colorectal
carcinoma. Cancer 79(12):2320–2328. https://doi.org/10.1002/(sici)1097-0142(19970615)79:
12<2320::aid-cncr5>3.0.co;2-p. PMID: 9191519
Deng L, Jiang N, Zeng J, Wang Y, Cui H (2021) The versatile roles of cancer-associated fibroblasts
in colorectal cancer and therapeutic implications. Front Cell Dev Biol 9:733270. https://doi.org/
10.3389/fcell.2021.733270. PMID: 34660589; PMCID: PMC8517274
Deschoolmeester V, Baay M, Van Marck E, Weyler J, Vermeulen P, Lardon F, Vermorken JB
(2010) Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer
patients. BMC Immunol 11:19. https://doi.org/10.1186/1471-2172-11-19. PMID: 20385003;
PMCID: PMC2864219
Edin S, Wikberg ML, Dahlin AM, Rutegård J, Öberg Å, Oldenborg PA, Palmqvist R (2012) The
distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the
molecular characteristics of colorectal cancer. PLoS One 7(10):e47045. https://doi.org/10.
1371/journal.pone.0047045. Epub 2012 Oct 15. PMID: 23077543; PMCID: PMC3471949
Edin S, Kaprio T, Hagström J, Larsson P, Mustonen H, Böckelman C, Strigård K, Gunnarsson U,
Haglund C, Palmqvist R (2019) The prognostic importance of CD20+ B lymphocytes in
colorectal cancer and the relation to other immune cell subsets. Sci Rep 9(1):19997. https://
doi.org/10.1038/s41598-019-56441-8. PMID: 31882709; PMCID: PMC6934737
Eriksen AC, Sørensen FB, Lindebjerg J, Hager H, dePont Christensen R, Kjær-Frifeldt S, Hansen
TF (2018) The prognostic value of tumor-infiltrating lymphocytes in stage II colon cancer. A
nationwide population-based study. Transl Oncol 11(4):979–987. https://doi.org/10.1016/j.
tranon.2018.03.008. Epub 2018 Jun 22. PMID: 29940413; PMCID: PMC6039294
Flaherty DC, Lavotshkin S, Jalas JR, Torisu-Itakura H, Kirchoff DD, Sim MS, Lee DJ, Bilchik AJ
(2016) Prognostic utility of immunoprofiling in colon cancer: results from a prospective,
multicenter nodal ultrastaging trial. J Am Coll Surg 223(1):134–140. https://doi.org/10.1016/j.
jamcollsurg.2016.03.003. Epub 2016 Mar 18. PMID: 27282965
Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R (2007) High macrophage
infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer
Res 13(5):1472–1479. https://doi.org/10.1158/1078-0432.CCR-06-2073. PMID: 17332291
Fridman WH, Miller I, Sautès-Fridman C, Byrne AT (2020) Therapeutic targeting of the colorectal
tumor stroma. Gastroenterology 158(2):303–321. https://doi.org/10.1053/j.gastro.2019.09.045.
Epub 2019 Oct 14. PMID: 31622621
Galindo-Pumariño C, Collado M, Herrera M, Peña C (2021) Tumor microenvironment in metastatic
colorectal cancer: the arbitrator in patients’ outcome. Cancers (Basel) 13:1130
Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M,
Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman
WH, Pagès F (2006) Type, density, and location of immune cells within human colorectal
tumors predict clinical outcome. Science 313(5795):1960–1964. https://doi.org/10.1126/
science.1129139. PMID: 17008531
Galon J, Mlecnik B, Bindea G, Angell HK, Berger A, Lagorce C, Lugli A, Zlobec I, Hartmann A,
Bifulco C, Nagtegaal ID, Palmqvist R, Masucci GV, Botti G, Tatangelo F, Delrio P, Maio M,
Laghi L, Grizzi F, Asslaber M, D’Arrigo C, Vidal-Vanaclocha F, Zavadova E, Chouchane L,
The Role of Tumor Microenvironment in Colon Cancer 207
https://t.me/med1917
Ohashi PS, Hafezi-Bakhtiari S, Wouters BG, Roehrl M, Nguyen L, Kawakami Y, Hazama S,
Okuno K, Ogino S, Gibbs P, Waring P, Sato N, Torigoe T, Itoh K, Patel PS, Shukla SN,
Wang Y, Kopetz S, Sinicrope FA, Scripcariu V, Ascierto PA, Marincola FM, Fox BA, Pagès F
(2014) Towards the introduction of the ‘Immunoscore’ in the classification of malignant
tumours. J Pathol 232(2):199–209. https://doi.org/10.1002/path.4287. PMID: 24122236;
PMCID: PMC4255306
Galon J, Mlecnik B, Marliot F, Ou F, Bifulco CB, Lugli A, Zlobec I, Rau T, Hartmann A, Masucci
GV, Zavadova E, Ohashi P, Roehrl M, Kawakami Y, Torigoe T, Ascierto PT, Marincola F,
Sargent D, Fox B, Pages F (2016) Validation of the Immunoscore (IM) as a prognostic marker in
stage I/II/III colon cancer: results of a worldwide consortium-based analysis of 1,336 patients.
J Clin Oncol 34(15_suppl):3500
Ganesh K, Stadler ZK, Cercek A, Mendelsohn RB, Shia J, Segal NH, Diaz LA Jr (2019)
Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol
Hepatol 16(6):361–375. https://doi.org/10.1038/s41575-019-0126-x. PMID: 30886395;
PMCID: PMC7295073
Global Cancer Observatory (2020). https://gco.iarc.fr/. Accessed Jan 2022
Graham DM, Appelman HD (1990) Crohn’s-like lymphoid reaction and colorectal carcinoma: a
potential histologic prognosticator. Mod Pathol 3(3):332–335. PMID: 2362940
Guidoboni M, Gafà R, Viel A, Doglioni C, Russo A, Santini A, Del Tin L, Macrì E, Lanza G,
Boiocchi M, Dolcetti R (2001) Microsatellite instability and high content of activated cytotoxic
lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol 159(1):
297–304. https://doi.org/10.1016/S0002-9440(10)61695-1. PMID: 11438476; PMCID:
PMC1850401
Hanke T, Melling N, Simon R, Sauter G, Bokemeyer C, Lebok P, Terracciano LM, Izbicki JR,
Marx AH (2015) High intratumoral FOXP3
good prognosticator in nodal negative colorectal cancer. Int J Clin Exp Pathol 8(7):
8227–8235. PMID: 26339391; PMCID: PMC4555719
Heichler C, Scheibe K, Schmied A, Geppert CI, Schmid B, Wirtz S, Thoma OM, Kramer V,
Waldner MJ, Büttner C, Farin HF, Pešić M, Knieling F, Merkel S, Grüneboom A, Gunzer M,
Grützmann R, Rose-John S, Koralov SB, Kollias G, Vieth M, Hartmann A, Greten FR, Neurath
MF, Neufert C (2020) STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts
promotes colorectal tumour development and correlates with poor prognosis. Gut 69(7):
1269–1282. https://doi.org/10.1136/gutjnl-2019-319200. Epub 2019 Nov 4. PMID: 31685519
Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada
MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM,
Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F,
Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C,
Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F,
Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J,
Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ,
Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O'Toole S, Larsimont D, de
Wind R, Curigliano G, André F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S,
Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH,
Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV,
Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele
KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB (2017) Assessing
tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal
for a standardized method from the International Immuno-Oncology Biomarkers Working
Group: part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carci-
noma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the
head and neck, genitourinary carcinomas, and primary brain tumors. Adv Anat Pathol 24(6):
311–335. https://doi.org/10.1097/PAP.0000000000000161. PMID: 28777143; PMCID:
PMC5638696
+
T regulatory cell (Tregs) density is an independent
208 C. Fattorini et al.
https://t.me/med1917
Hermitte F (2016) Biomarkers immune monitoring technology primer: Immunoscore® colon.
J Immunother Cancer 4:57. https://doi.org/10.1186/s40425-016-0161-x. PMID: 27660711;
PMCID: PMC5029002
Herrera M, Herrera A, Domínguez G, Silva J, García V, García JM, Gómez I, Soldevilla B,
Muñoz C, Provencio M, Campos-Martin Y, García de Herreros A, Casal I, Bonilla F, Peña C
(2013) Cancer-associated fibroblast and M2 macrophage markers together predict outcome in
colorectal cancer patients. Cancer Sci 104(4):437–444. https://doi.org/10.1111/cas.12096. Epub
2013 Feb 21. PMID: 23298232; PMCID: PMC7657228
House AK, Watt AG (1979) Survival and the immune response in patients with carcinoma of the
colorectum. Gut 20(10):868–874. https://doi.org/10.1136/gut.20.10.868. PMID: 533699;
PMCID: PMC1412722
Huijbers A, Tollenaar RA, v Pelt GW, Zeestraten EC, Dutton S, McConkey CC, Domingo E, Smit
VT, Midgley R, Warren BF, Johnstone EC, Kerr DJ, Mesker WE (2013) The proportion of
tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in
the VICTOR trial. Ann Oncol 24(1):179–185. https://doi.org/10.1093/annonc/mds246. Epub
2012 Aug 2. PMID: 22865778
Hynes SO, Coleman HG, Kelly PJ, Irwin S, O’Neill RF, Gray RT, McGready C, Dunne PD,
McQuaid S, James JA, Salto-Tellez M, Loughrey MB (2017) Back to the future: routine
morphological assessment of the tumour microenvironment is prognostic in stage II/III colon
cancer in a large population-based study. Histopathology 71(1):12–26. https://doi.org/10.1111/
his.13181. Epub 2017 Apr 3. PMID: 28165633
Iseki Y, Shibutani M, Maeda K, Nagahara H, Fukuoka T, Matsutani S, Kashiwagi S, Tanaka H,
Hirakawa K, Ohira M (2018) A new method for evaluating tumor-infiltrating lymphocytes
(TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections. PLoS
One 13(4):e0192744. https://doi.org/10.1371/journal.pone.0192744. PMID: 29698402;
PMCID: PMC5919485
Jass JR (1986) Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol 39(6):585–589.
https://doi.org/10.1136/jcp.39.6.585. PMID: 3722412; PMCID: PMC499954
Kamal Y, Schmit SL, Frost HR, Amos CI (2020) The tumor microenvironment of colorectal cancer
metastases: opportunities in cancer immunotherapy. Immunotherapy 12(14):1083–1100. https://
doi.org/10.2217/imt-2020-0026. Epub 2020 Aug 13. PMID: 32787587; PMCID: PMC8411393
Katz SC, Pillarisetty V, Bamboat ZM, Shia J, Hedvat C, Gonen M, Jarnagin W, Fong Y,
Blumgart L, D’Angelica M, DeMatteo RP (2009) T cell infiltrate predicts long-term survival
following resection of colorectal cancer liver metastases. Ann Surg Oncol 16(9):2524–2530.
https://doi.org/10.1245/s10434-009-0585-3. Epub 2009 Jul 1. PMID: 19568816
Kim Y, Bae JM, Li G, Cho NY, Kang GH (2015) Image analyzer-based assessment of tumor-
infiltrating T cell subsets and their prognostic values in colorectal carcinomas. PLoS One 10(4):
e0122183. https://doi.org/10.1371/journal.pone.0122183. PMID: 25875774; PMCID:
PMC4398542
Klintrup K, Mäkinen JM, Kauppila S, Väre PO, Melkko J, Tuominen H, Tuppurainen K, Mäkelä J,
Karttunen TJ, Mäkinen MJ (2005) Inflammation and prognosis in colorectal cancer. Eur J
Cancer 41(17):2645–2654. https://doi.org/10.1016/j.ejca.2005.07.017. Epub 2005 Oct
18. PMID: 16239109
Korehisa S, Oki E, Iimori M, Nakaji Y, Shimokawa M, Saeki H, Okano S, Oda Y, Maehara Y
(2018) Clinical significance of programmed cell death-ligand 1 expression and the immune
microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
Int J Cancer 142(4):822–832.
29044503
Kudo A (2019) Clinical applications targeting periostin. Adv Exp Med Biol 1132:207–210. https://
doi.org/10.1007/978-981-13-6657-4_19. PMID: 31037637
Laghi L, Bianchi P, Miranda E, Balladore E, Pacetti V, Grizzi F, Allavena P, Torri V, Repici A,
Santoro A, Mantovani A, Roncalli M, Malesci A (2009) CD3+ cells at the invasive margin of
deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal
https://doi.org/10.1002/ijc.31107. Epub 2017 Oct 31. PMID:
The Role of Tumor Microenvironment in Colon Cancer 209
https://t.me/med1917
study. Lancet Oncol 10(9):877–884. https://doi.org/10.1016/S1470-2045(09)70186-X. Epub
2009 Aug 3. PMID: 19656725
Lavotshkin S, Jalas JR, Torisu-Itakura H, Ozao-Choy J, Lee JH, Sim MS, Stojadinovic A,
Wainberg Z, Bifulco CB, Fox BA, Bilchik AJ (2015) Immunoprofiling for prognostic assess-
ment of colon cancer: a novel complement to ultrastaging. J Gastrointest Surg 19(6):999–1006.
https://doi.org/10.1007/s11605-015-2759-6. Epub 2015 Mar 26. PMID: 25808375; PMCID:
PMC4720974
Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS,
Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM,
Goldberg RM, de la Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD,
Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders
RA, Eshleman JR, Vogelstein B, Diaz LA Jr (2015) PD-1 blockade in tumors with mismatch-
repair deficiency. N Engl J Med 372(26):2509–2520. https://doi.org/10.1056/NEJMoa1500596.
Epub 2015 May 30. PMID: 26028255; PMCID: PMC4481136
Li S, Xu F, Zhang J, Wang L, Zheng Y, Wu X, Wang J, Huang Q, Lai M (2017) Tumor-associated
macrophages remodeling EMT and predicting survival in colorectal carcinoma.
Oncoimmunology 7(2):e1380765. https://doi.org/10.1080/2162402X.2017.1380765. PMID:
29416940; PMCID: PMC5798198
Lin Q, Ke J, Yu Z, Cao Y, Lai Y, Chen Y, Gao F, Wang X (2021) Identification of prognostic
spatial organization features in colorectal cancer microenvironment using deep learning on
histopathology images. Med Omics 2:100008
Ling A, Edin S, Wikberg ML, Öberg Å, Palmqvist R (2014) The intratumoural subsite and relation
of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic
clues. Br J Cancer 110(10):2551–2559. https://doi.org/10.1038/bjc.2014.161. Epub 2014 Mar
27. PMID: 24675384; PMCID: PMC4021513
Liska V, Vycital O, Daum O, Novak P, Treska V, Bruha J, Pitule P, Holubec L (2012) Infiltrationof
colorectal carcinoma by S100+ dendritic cells and CD57+ lymphocytes as independent prog-
nostic factors after radical surgical treatment. Anticancer Res 32(5):2129–2132. PMID:
22593500
Liu JW, Yu F, Tan YF, Huo JP, Liu Z, Wang XJ, Li JM (2020) Profiling of tumor microenviron-
ment components identifies five stroma-related genes with prognostic implications in colorectal
cancer. Cancer Biother Radiopharm. https://doi.org/10.1089/cbr.2020.4118. Epub ahead of
print. PMID: 33085921
Loddenkemper C, Schernus M, Noutsias M, Stein H, Thiel E, Nagorsen D (2006) In situ analysis of
FOXP3+ regulatory T cells in human colorectal cancer. J Transl Med 4:52. https://doi.org/10.
1186/1479-5876-4-52. PMID: 17166272; PMCID: PMC1764431
Ma H, Wang J, Zhao X, Wu T, Huang Z, Chen D, Liu Y, Ouyang G (2020) Periostin promotes
colorectal tumorigenesis through integrin-FAK-Src pathway-mediated YAP/TAZ activation.
Cell Rep 30(3):793–806.e6. https://doi.org/10.1016/j.celrep.2019.12.075. PMID: 31968254
Mahnke YD, Brodie TM, Sallusto F, Roederer M, Lugli E (2013) The who’s who of T-cell
differentiation: human memory T-cell subsets. Eur J Immunol 43(11):2797–2809. https://doi.
org/10.1002/eji.201343751. Epub 2013 Oct 30. PMID: 24258910
Märkl B, Paul B, Schaller T, Kretsinger H, Kriening B, Schenkirsch G (2017) The role of lymph
node size and FOXP3+ regulatory T cells in node-negative colon cancer. J Clin Pathol 70(5):
443–447. https://doi.org/10.1136/jclinpath-2016-203978. Epub 2016 Nov 22. PMID: 27879345
Matsutani S, Shibutani M, Maeda K, Nagahara H, Fukuoka T, Iseki Y, Hirakawa K, Ohira M (2018)
Verification of the methodology for evaluating tumor-infiltrating lymphocytes in colorectal
cancer. Oncotarget 9(20):15180–
29632635; PMCID: PMC5880595
McAndrews KM, Vázquez-Arreguín K, Kwak C, Sugimoto H, Zheng X, Li B, Kirtley ML, LeBleu
VS, Kalluri R (2021) αSMA
cancer progression. Oncogene 40(26):4440–4452. https://doi.org/10.1038/s41388-021-
01866-7. Epub 2021 Jun 9. PMID: 34108617
15197. https://doi.org/10.18632/oncotarget.24612. PMID:
+
fibroblasts suppress Lgr5+cancer stem cells and restrain colorectal
210 C. Fattorini et al.
https://t.me/med1917
Menon AG, Janssen-van Rhijn CM, Morreau H, Putter H, Tollenaar RA, van de Velde CJ, Fleuren
GJ, Kuppen PJ (2004) Immune system and prognosis in colorectal cancer: a detailed immuno-
histochemical analysis. Lab Invest 84(4):493–501. https://doi.org/10.1038/labinvest.
3700055. PMID: 14968119
Meshcheryakova A, Tamandl D, Bajna E, Stift J, Mittlboeck M, Svoboda M, Heiden D,
Stremitzer S, Jensen-Jarolim E, Grünberger T, Bergmann M, Mechtcheriakova D (2014) B
cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic
power for patients with metastatic colorectal cancer. PLoS One 9(6):e99008. https://doi.org/10.
1371/journal.pone.0099008. PMID: 24905750; PMCID: PMC4048213
Mesker WE, Liefers GJ, Junggeburt JM, van Pelt GW, Alberici P, Kuppen PJ, Miranda NF, van
Leeuwen KA, Morreau H, Szuhai K, Tollenaar RA, Tanke HJ (2009) Presence of a high amount
of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer
patients. Cell Oncol 31(3):169–178. https://doi.org/10.3233/CLO-2009-0478. PMID:
19478385; PMCID: PMC4618830
Miller TJ, McCoy MJ, Hemmings C, Bulsara MK, Iacopetta B, Platell CF (2017) The prognostic
value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by
expression of the immune-related markers FoxP3, PD-L1 and CD3. Pathology 49(7):721–730.
https://doi.org/10.1016/j.pathol.2017.08.007. Epub 2017 Nov 6. PMID: 29102042
Mizuno R, Kawada K, Itatani Y, Ogawa R, Kiyasu Y, Sakai Y (2019) The role of tumor-associated
neutrophils in colorectal cancer. Int J Mol Sci 20(3):529. https://doi.org/10.3390/
ijms20030529. PMID: 30691207; PMCID: PMC6386937
Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, Bruneval P, Trajanoski Z,
Fridman WH, Pagès F, Galon J (2011) Histopathologic-based prognostic factors of colorectal
cancers are associated with the state of the local immune reaction. J Clin Oncol 29(6):610–618.
https://doi.org/10.1200/JCO.2010.30.5425. Epub 2011 Jan 18. PMID: 21245428
Mlecnik B, Bindea G, Angell HK, Maby P, Angelova M, Tougeron D, Church SE, Lafontaine L,
Fischer M, Fredriksen T, Sasso M, Bilocq AM, Kirilovsky A, Obenauf AC, Hamieh M,
Berger A, Bruneval P, Tuech JJ, Sabourin JC, Le Pessot F, Mauillon J, Rafii A, Laurent-
Puig P, Speicher MR, Trajanoski Z, Michel P, Sesboüe R, Frebourg T, Pagès F, Valge-Archer V,
Latouche JB, Galon J (2016) Integrative analyses of colorectal cancer show immunoscore is a
stronger predictor of patient survival than microsatellite instability. Immunity 44(3):698–711.
https://doi.org/10.1016/j.immuni.2016.02.025. PMID: 26982367
Mori K, Toiyama Y, Saigusa S, Fujikawa H, Hiro J, Kobayashi M, Ohi M, Araki T, Inoue Y,
Tanaka K, Mohri Y, Kusunoki M (2015) Systemic analysis of predictive biomarkers for
recurrence in colorectal cancer patients treated with curative surgery. Dig Dis Sci 60(8):
2477–2487. https://doi.org/10.1007/s10620-015-3648-2. Epub 2015 Apr 4. PMID: 25840921
Murray D, Hreno A, Dutton J, Hampson LG (1975) Prognosis in colon cancer: a pathologic
reassessment. Arch Surg 110(8):908– 913. https://do i.org/10.1001/archsurg.1975.
01360140052011. PMID: 1156157
Nagtegaal ID, Marijnen CA, Kranenbarg EK, Mulder-Stapel A, Hermans J, van de Velde CJ, van
Krieken JH (2001) Local and distant recurrences in rectal cancer patients are predicted by the
nonspecific immune response; speci fic immune response has only a systemic effect – a
histopathological and immunohistochemical study. BMC Cancer 1:7. https://doi.org/10.1186/
1471-2407-1-7. Epub 2001 Jul 16. PMID: 11481031; PMCID: PMC35356
Nearchou IP, Lillard K, Gavriel CG, Ueno H, Harrison DJ, Caie PD (2019) Automated analysis of
lymphocytic infiltration, tumor budding, and their spatial relationship improves prognostic
accuracy in colorectal cancer. Cancer Immunol Res 7(4):609–620. https://doi.org/10.1158/
2326-6066.CIR-18-0377. Epub 2019 Mar 7. Erratum in: Cancer Immunol Res. 2019 Aug;7(8):
1381. PMID: 30846441
Nearchou IP, Gwyther BM, Georgiakakis ECT, Gavriel CG, Lillard K, Kajiwara Y, Ueno H,
Harrison DJ, Caie PD (2020) Spatial immune profiling of the colorectal tumor microenviron-
ment predicts good outcome in stage II patients. NPJ Digit Med 3:71. https://doi.org/10.1038/
s41746-020-0275-x
. PMID: 32435699; PMCID: PMC7229187
The Role of Tumor Microenvironment in Colon Cancer 211
https://t.me/med1917
Nearchou IP, Soutar DA, Ueno H, Harrison DJ, Arandjelovic O, Caie PD (2021) A comparison of
methods for studying the tumor microenvironment’s spatial heterogeneity in digital pathology
specimens. J Pathol Inform 12:6. https://doi.org/10.4103/jpi.jpi_26_20. PMID: 34012710;
PMCID: PMC8112337
Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G,
Fuchs CS, Ogino S (2010) Tumour-infiltrating T-cell subsets, molecular changes in colorectal
cancer, and prognosis: cohort study and literature review. J Pathol 222(4):350–366. https://doi.
org/10.1002/path.2774. PMID: 20927778; PMCID: PMC3033700
Ogino S, Nosho K, Irahara N, Meyerhardt JA, Baba Y, Shima K, Glickman JN, Ferrone CR, Mino-
Kenudson M, Tanaka N, Dranoff G, Giovannucci EL, Fuchs CS (2009) Lymphocytic reaction
to colorectal cancer is associated with longer survival, independent of lymph node count,
microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res 15(20):
6412–6420. https://doi.org/10.1158/1078-0432.CCR-09-1438. Epub 2009 Oct 13. PMID:
19825961; PMCID: PMC2771425
Overman MJ, Lonardi S, Wong KYM, Lenz HJ, Gelsomino F, Aglietta M, Morse MA, Van
Cutsem E, McDermott R, Hill A, Sawyer MB, Hendlisz A, Neyns B, Svrcek M, Moss RA,
Ledeine JM, Cao ZA, Kamble S, Kopetz S, André T (2018) Durable clinical benefit with
nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high
metastatic colorectal cancer. J Clin Oncol 36(8):773–779. https://doi.org/10.1200/JCO.2017.76.
9901. Epub 2018 Jan 20. PMID: 29355075
Pagès F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, Lagorce C, Wind P,
Marliot F, Bruneval P, Zatloukal K, Trajanoski Z, Berger A, Fridman WH, Galon J (2009) In
situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.
J Clin Oncol 27(35):5944–5951. https://doi.org/10.1200/JCO.2008.19.6147. Epub 2009 Oct
26. PMID: 19858404
Pagès F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger
MD, Nagtegaal ID, Vink-Börger E, Hartmann A, Geppert C, Kolwelter J, Merkel S,
Grützmann R, Van den Eynde M, Jouret-Mourin A, Kartheuser A, Léonard D, Remue C,
Wang JY, Bavi P, Roehrl MHA, Ohashi PS, Nguyen LT, Han S, MacGregor HL, Hafezi-
Bakhtiari S, Wouters BG, Masucci GV, Andersson EK, Zavadova E, Vocka M, Spacek J,
Petruzelka L, Konopasek B, Dundr P, Skalova H, Nemejcova K, Botti G, Tatangelo F, Delrio P,
Ciliberto G, Maio M, Laghi L, Grizzi F, Fredriksen T, Buttard B, Angelova M, Vasaturo A,
Maby P, Church SE, Angell HK, Lafontaine L, Bruni D, El Sissy C, Haicheur N, Kirilovsky A,
Berger A, Lagorce C, Meyers JP, Paustian C, Feng Z, Ballesteros-Merino C, Dijkstra J, van de
Water C, van Lent-van Vliet S, Knijn N, Mușină AM, Scripcariu DV, Popivanova B, Xu M,
Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N, Furuhata T,
Takemasa I, Itoh K, Patel PS, Vora HH, Shah B, Patel JB, Rajvik KN, Pandya SJ, Shukla
SN, Wang Y, Zhang G, Kawakami Y, Marincola FM, Ascierto PA, Sargent DJ, Fox BA, Galon
J. International validation of the consensus Immunoscore for the classification of colon cancer: a
prognostic and accuracy study. Lancet 2018;391(10135):2128–2139. https://doi.org/10.1016/
S0140-6736(18)30789-X. Epub 2018 May 10. PMID: 29754777
Paget S (1989) The distribution of secondary growths in cancer of the breast. 1889. Cancer
Metastasis Rev 8(2):98–101. PMID: 2673568
Pernot S, Terme M, Voron T, Colussi O, Marcheteau E, Tartour E, Taieb J (2014) Colorectal cancer
and immunity: what we know and perspectives. World J Gastroenterol 20(14):3738–3750.
https://doi.org/10.3748/wjg.v20.i14.3738. PMID: 24833840; PMCID: PMC3983433
Phillips SM, Banerjea A, Feakins R, Li SR, Bustin SA, Dorudi S (2004) Tumour-infiltrating
lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic.
Br J Surg 91(4):469–475. https://doi.org/10.1002/bjs.4472. PMID: 15048750
Pietras K, Ostman A (2010) Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res
316(8):1324–1331. https://doi.org/10.1016/j.yexcr.2010.02.045. Epub 2010 Mar 6. PMID:
20211171
212 C. Fattorini et al.
https://t.me/med1917
Prall F, Hühns M (2017) The PD-1 expressing immune phenotype of T cell exhaustion is prominent
in the ‘immunoreactive’ microenvironment of colorectal carcinoma. Histopathology 71(3):
366–374. https://doi.org/10.1111/his.13231. Epub 2017 Jun 9. PMID: 28383777
Prizment AE, Vierkant RA, Smyrk TC, Tillmans LS, Nelson HH, Lynch CF, Pengo T, Thibodeau
SN, Church TR, Cerhan JR, Anderson KE, Limburg PJ (2017) Cytotoxic T cells and granzyme
B associated with improved colorectal cancer survival in a prospective cohort of older women.
Cancer Epidemiol Biomarkers Prev 26(4):622–631. https://doi.org/10.1158/1055-9965.EPI-
16-0641. Epub 2016 Dec 15. PMID: 27979806; PMCID: PMC5380516
Rao HL, Chen JW, Li M, Xiao YB, Fu J, Zeng YX, Cai MY, Xie D (2012) Increased intratumoral
neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts
patients’ adverse prognosis. PLoS One 7(1):e30806. https://doi.org/10.1371/journal.pone.
0030806. Epub 2012 Jan 25. PMID: 22295111; PMCID: PMC3266280
Richards CH, Roxburgh CS, Powell AG, Foulis AK, Horgan PG, McMillan DC (2014) The clinical
utility of the local inflammatory response in colorectal cancer. Eur J Cancer 50(2):309–319.
https://doi.org/10.1016/j.ejca.2013.09.008. Epub 2013 Oct 5. PMID: 24103145
Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM (1997) Prognostic value of
tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182(3):318–324. https://
doi.org/10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6. PMID:
9349235
Rozek LS, Schmit SL, Greenson JK, Tomsho LP, Rennert HS, Rennert G, Gruber SB (2016)
Tumor-infiltrating lymphocytes, Crohn’s-like lymphoid reaction, and survival from colorectal
cancer. J Natl Cancer Inst 108(8):djw027. https://doi.org/10.1093/jnci/djw027. PMID:
27172903; PMCID: PMC5017930
Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR,
Hingorani SR, Hunter T, Hynes RO, Jain RK, Janowitz T, Jorgensen C, Kimmelman AC,
Kolonin MG, Maki RG, Powers RS, Puré E, Ramirez DC, Scherz-Shouval R, Sherman MH,
Stewart S, Tlsty TD, Tuveson DA, Watt FM, Weaver V, Weeraratna AT, Werb Z (2020) A
framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer
20(3):174–186. https://doi.org/10.1038/s41568-019-0238-1. Epub 2020 Jan 24. PMID:
31980749; PMCID: PMC7046529
Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B (2009) Tumor-
infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
J Clin Oncol 27(2):186–192. https://doi.org/10.1200/JCO.2008.18.7229. Epub 2008 Dec
8. PMID: 19064967
Samowitz WS (2015) Evaluation of colorectal cancers for Lynch syndrome: practical molecular
diagnostics for surgical pathologists. Mod Pathol 28(Suppl 1):S109 –S113. https://doi.org/10.
1038/modpathol.2014.127. PMID: 25560596
Sawicki T, Ruszkowska M, Danielewicz A, Niedźwiedzka E, Arłukowicz T, Przybyłowicz KE
(2021) A review of colorectal cancer in terms of epidemiology, risk factors, development,
symptoms and diagnosis. Cancers (Basel) 13(9):2025. https://doi.org/10.3390/
cancers13092025. PMID: 33922197; PMCID: PMC8122718
Schweiger T, Berghoff AS, Glogner C, Glueck O, Rajky O, Traxler D, Birner P, Preusser M,
Klepetko W, Hoetzenecker K (2016) Tumor-infiltrating lymphocyte subsets and tertiary lym-
phoid structures in pulmonary metastases from colorectal cancer. Clin Exp Metastasis 33(7):
727–739. https://doi.org/10.1007/s10585-016-9813-y. Epub 2016 Jul 23. PMID: 27449756;
PMCID: PMC5035322
Sinicrope FA, Rego RL, Ansell SM, Knutson KL, Foster NR, Sargent DJ (2009) Intraepithelial
effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon
carcinoma. Gastroenterology 137(4):1270–1279. https://doi.org/10.1053/j.gastro.2009.06.053.
Epub 2009 Jul 3. PMID: 19577568; PMCID: PMC2873775
Son GM, Kwon MS, Shin DH, Shin N, Ryu D, Kang CD (2019) Comparisons of cancer-associated
fibroblasts in the intratumoral stroma and invasive front in colorectal cancer. Medicine
(Baltimore) 98(18):e15164. https://doi.org/10.1097/MD.0000000000015164. PMID:
31045759; PMCID: PMC6504275
The Role of Tumor Microenvironment in Colon Cancer 213
https://t.me/med1917
Souza da Silva RM, Queiroga EM, Paz AR, Neves FFP, Cunha KS, Dias EP (2021) Standardized
assessment of the tumor-stroma ratio in colorectal cancer: interobserver validation and repro-
ducibility of a potential prognostic factor. Clin Pathol 14:2632010X21989686. https://doi.org/
10.1177/2632010X21989686. PMID: 33634262; PMCID: PMC7887673
Spratt JS Jr, Spjut HJ (1967) Prevalence and prognosis of individual clinical and pathologic
variables associated with colorectal carcinoma. Cancer 20(11):1976–1985. https://doi.org/10.
1002/1097-0142(196711)20:11<1976::aid-cncr2820201125>3.0.co;2-m. PMID: 6061631
Suzuki H, Chikazawa N, Tasaka T, Wada J, Yamasaki A, Kitaura Y, Sozaki M, Tanaka M,
Onishi H, Morisaki T, Katano M (2010) Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a
predictive marker for survival in patients with colorectal cancer. Cancer Immunol Immunother
59(5):653–661. https://doi.org/10.1007/s00262-009-0781-9. Epub 2009 Nov 12. PMID:
19908042
Svennevig JL, Lunde OC, Holter J, Bjørgsvik D (1984) Lymphoid infiltration and prognosis in
colorectal carcinoma. Br J Cancer 49(3):375–377. https://doi.org/10.1038/bjc.1984.60. PMID:
6704315; PMCID: PMC1976736
Tachibana T, Onodera H, Tsuruyama T, Mori A, Nagayama S, Hiai H, Imamura M (2005)
Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary
colorectal carcinomas. Clin Cancer Res 11(20):7322–7327. https://doi.org/10.1158/1078-0432.
CCR-05-0877. PMID: 16243803
Takemoto N, Konishi F, Yamashita K, Kojima M, Furukawa T, Miyakura Y, Shitoh K, Nagai H
(2004) The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hered-
itary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance
of different types of lymphocyte infiltration. Jpn J Clin Oncol 34(2):90–98. https://doi.org/10.
1093/jjco/hyh018. PMID: 15067103
Teng F, Mu D, Meng X, Kong L, Zhu H, Liu S, Zhang J, Yu J (2015) Tumor infiltrating
lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for
rectal cancer. Am J Cancer Res 5(6):2064–2074. PMID: 26269765; PMCID: PMC4529625
Tsou P, Katayama H, Ostrin EJ, Hanash SM (2016) The emerging role of B cells in tumor
immunity. Cancer Res 76(19):5597–5601. https://doi.org/10.1158/0008-5472.CAN-16-0431.
Epub 2016 Sep 15. PMID: 27634765
Tsujino T, Seshimo I, Yamamoto H, Ngan CY, Ezumi K, Takemasa I, Ikeda M, Sekimoto M,
Matsuura N, Monden M (2007) Stromal myofibroblasts predict disease recurrence for colorectal
cancer. Clin Cancer Res 13(7):2082– 2090. https://doi.org/10.1158/1078-0432.CCR-
06-2191. PMID: 17404090
Ueno H, Hashiguchi Y, Shimazaki H, Shinto E, Kajiwara Y, Nakanishi K, Kato K, Maekawa K,
Miyai K, Nakamura T, Yamamoto J, Hase K (2013) Objective criteria for crohn-like lymphoid
reaction in colorectal cancer. Am J Clin Pathol 139(4):434–441. https://doi.org/10.1309/
AJCPWHUEFTGBWKE4. PMID: 23525613
Van den Eynde M, Mlecnik B, Bindea G, Fredriksen T, Church SE, Lafontaine L, Haicheur N,
Marliot F, Angelova M, Vasaturo A, Bruni D, Jouret-Mourin A, Baldin P, Huyghe N,
Haustermans K, Debucquoy A, Van Cutsem E, Gigot JF, Hubert C, Kartheuser A, Remue C,
Léonard D, Valge-Archer V, Pagès F, Machiels JP, Galon J (2018) The link between the
multiverse of immune microenvironments in metastases and the survival of colorectal cancer
patients. Cancer Cell 34(6):1012–1026.e3. https://doi.org/10.1016/j.ccell.2018.11.003. PMID:
30537506
Van Pelt GW, Hansen TF, Bastiaannet E, Frifeldt SK, Van Krieken JH, Tollenaar RA, Sorensen FB,
Mesker WE (2016) Stroma-high lymph node involvement predicts poor survival more accu-
rately for patients with stage III colon cancer. J Med Surg Pathol 1:116. https://doi.org/10.4172/
jmsp.1000116
Van Pelt GW, Kjær-Frifeldt S, van Krieken JHJM, Al Dieri R, Morreau H, Tollenaar RAEM,
Sørensen FB, Mesker WE (2018) Scoring the tumor-stroma ratio in colon cancer: procedure and
recommendations. Virchows Arch 473(4):405–
Epub 2018 Jul 20. PMID: 30030621; PMCID: PMC6182321
412. https://doi.org/10.1007/s00428-018-2408-z.
214 C. Fattorini et al.
https://t.me/med1917
Väyrynen JP, Vornanen JO, Sajanti S, Böhm JP, Tuomisto A, Mäkinen MJ (2012) An improved
image analysis method for cell counting lends credibility to the prognostic significance of T cells
in colorectal cancer. Virchows Arch 460(5):455 – 465. https://doi.org/10.1007/s00428-012-
1232-0. Epub 2012 Apr 24. PMID: 22527018
Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S (2008) Functions of natural killer cells.
Nat Immunol 9(5):503–510. https://doi.org/10.1038/ni1582. PMID: 18425107
Wang Y, Dong J, Quan Q, Liu S, Chen X, Cai X, Qiu H, Zhang B, Guo G (2021a) Immune cell
infiltration of the primary tumor microenvironment predicted the treatment outcome of chemo-
therapy with or without bevacizumab in metastatic colorectal cancer patients. Front Oncol 10:
581051. https://doi.org/10.3389/fonc.2020.581051. PMID: 33585196; PMCID: PMC7873592
Wang H, Tian T, Zhang J (2021b) Tumor-associated macrophages (TAMs) in colorectal cancer
(CRC): from mechanism to therapy and prognosis. Int J Mol Sci 22(16):8470. https://doi.org/10.
3390/ijms22168470. PMID: 34445193; PMCID: PMC8395168
Watt AG, House AK (1978) Colonic carcinoma: a quantitative assessment of lymphocyte infiltra-
tion at the periphery of colonic tumors related to prognosis. Cancer 41(1):279–282. https://doi.
org/10.1002/1097-0142(197801)41:1<279::aid-cncr2820410139>3.0.co;2-b. PMID: 626936
Wherry EJ (2011) T cell exhaustion. Nat Immunol 12(6):492–499. https://doi.org/10.1038/ni.
2035. PMID: 21739672
Xie L, Jiang FC, Zhang LM, He WT, Liu JH, Li MQ, Zhang X, Xing S, Guo H, Zhou P (2015)
Targeting of MyD88 homodimerization by novel synthetic inhibitor TJ-M2010-5 in preventing
colitis-associated colorectal cancer. J Natl Cancer Inst 108(4):djv364. https://doi.org /10.1093/
jnci/djv364. PMID: 26712311
Yasuda K, Nirei T, Sunami E, Nagawa H, Kitayama J (2011) Density of CD4(+) and CD8(+)
T lymphocytes in biopsy samples can be a predictor of pathological response to
chemoradiotherapy (CRT) for rectal cancer. Radiat Oncol 6:49. https://doi.org/10.1186/1748-
717X-6-49. PMID: 21575175; PMCID: PMC3120676
Yuan Q, Gu J, Zhang J, Liu S, Wang Q, Tian T, Chen Z, Zhang J (2021) MyD88 in myofibroblasts
enhances colitis-associated tumorigenesis via promoting macrophage M2 polarization. Cell Rep
34(5):108724. https://doi.org/10.1016/j.celrep.2021.108724. PMID: 33535045
Zhang S, Bai W, Tong X, Bu P, Xu J, Xi Y (2019) Correlation between tumor microenvironment-
associated factors and the efficacy and prognosis of neoadjuvant therapy for rectal cancer. Oncol
Lett 17(1):1062–1070. https://doi.org/10.3892/ol.2018.9682. Epub 2018 Nov 9. PMID:
30655866; PMCID: PMC6313063
Соседние файлы в папке Библиотека им академика М.И. Перельмана